JNPSX
Price
$25.79
Change
-$0.32 (-1.23%)
Updated
Sep 20 closing price
VSIAX
Price
$85.86
Change
-$0.74 (-0.85%)
Updated
Sep 20 closing price
Ad is loading...

JNPSX vs VSIAX

Header iconJNPSX vs VSIAX Comparison
Open Charts JNPSX vs VSIAXBanner chart's image
Janus Henderson Small Cap Value D
Price$25.79
Change-$0.32 (-1.23%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.86
Change-$0.74 (-0.85%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JNPSX vs VSIAX Comparison Chart
Loading...
VS
JNPSX vs. VSIAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNPSX is a Buy and VSIAX is a Buy.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 57.3B vs. JNPSX (1.58B). VSIAX pays higher dividends than JNPSX: VSIAX (2.01) vs JNPSX (0.81). JNPSX was incepted earlier than VSIAX: JNPSX (37 years) vs VSIAX (13 years). JNPSX is a more actively managed with annual turnover of: 44.00 vs. VSIAX (16.00). JNPSX has a lower initial minimum investment than VSIAX: JNPSX (2500) vs VSIAX (3000). VSIAX (21.77) and JNPSX (20.92) have marching annual gain over last year. VSIAX return over 5 years is better than : 55.85 vs. JNPSX (25.88).
JNPSXVSIAXJNPSX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence37 years13 years-
Gain YTD11.34310.460108%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.58B57.3B3%
Annual Yield % from dividends0.812.0140%
Returns for 1 year20.9221.7796%
Returns for 3 years13.8617.8278%
Returns for 5 years25.8855.8546%
Returns for 10 years7.92102.738%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KUKE0.720.03
+3.83%
Kuke Music Holding Limited
HRB64.460.78
+1.22%
H&R Block
BKNG4063.9146.40
+1.15%
Booking Holdings
FARO18.06-0.15
-0.82%
FARO Technologies
VRDN22.30-0.20
-0.89%
Viridian Therapeutics